In some countries, patients considered vulnerable have received 3rd/4th COVID-19 vaccine doses (V3/V4). This study, presented by Stavros Dimitriadis (University of Oxford, Oxford, UK), explores the immune response to V4 in a mixed disease cohort of immunosuppressed patients including liver transplant recipients and patients with autoimmune hepatitis. This study also focused on individuals with absent or low antibody responses following their second vaccine dose.Â
The presentation entitled ‘Humoral and cellular immune responses to wild-type and omicron (B.1.1.529) SARS-CoV-2 variants following a fourth COVID-19 vaccination in liver transplant recipients and patients with autoimmune hepatitis (OS072)’ was given at ILC 2022, 22-26 June.Â
Disclosures: Stavros Dimitriadis has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.Â
Filmed as a highlight of ILC 2022
Click here for more COVID-19 content.
